The Market Value of the Global ENT Devices Market attained a value of USD 1,351.06 Million in 2020
The Market recorded a historical decline (CAGR) of 0.28 % between 2017 to 2020, and is expected to grow by...
GlobalData projects the Market to grow at a CAGR of ...
Will ENT Devices Recover in 2021 After Turbulent 2020?
With an aging population across the globe, the frequency of hearing loss is on the rise. The market for hearing implants is expected to grow similarly, and coupled with the return of elective procedures, the ear, nose, and throat (ENT) devices market will thrive for the near future.
The main driver of this growth is the resumption of elective ENT procedures that were delayed or cancelled in 2020 due to the COVID-19 pandemic. GlobalData estimates that elective procedures will recommence in 2021 and continue to address the backlog from the previous year. In 2020, the speech aid devices market suffered low-double digit revenue losses. However, GlobalData estimates this market to recover by low-double digit in 2021.
The ENT market recovery is backed by financial statements of the leading ENT manufacturers. For instance, Medtronic reported mid-double digit increase in its ENT portfolio revenue for the fourth quarter ending on April 30, 2021.
Chronic sinusitis and ENT devices market
Sanovas, Inc, a life science asset holding company and medical technology accelerator, announced today the launch of its wholly-owned subsidiary, SinuGeniX, Inc. and its RegENT™ Sinus Treatment System.
Sinusitis is one of the most prevalent of human diseases, second only to periodontal disease. Both conditions involve biofilm infections and undesirable host inflammatory responses. According to the Centers of Disease Control and Prevention (CDC), in the U.S., about 12.1% of the adult population or 28.5 Million people are suffering from chronic sinusitis, making it more prevailing than diabetes and asthma.
Chronic sinusitis patients are typically first treated with medications such as nasal steroids, decongestants, antihistamines, saline solutions and antibiotics. Although treatment with these medications is often successful, patients can experience side effects with long term use.
The high prevalence of chronic sinusitis has been driving the demand for ENT treatments such as endoscopic sinus surgeries, functional endoscopic sinus surgery (FESS), and balloon sinus dilatation. Thus, the growing prevalence of sinusitis is expected to propel the growth of the ENT devices market.
United States of America
United States of America
Ireland
Germany
Germany
United States of America
Netherlands
United States of America
United States of America
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward